Author pages are created from data sourced from our academic publisher partnerships and public sources.
Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine.
IMPORTANCE Since publication of the report by the Panel on Cost-Effectiveness in Health and Medicine in 1996, researchers have advanced the methods of cost-effectiveness analysis, and policy makers… Expand
Updating cost-effectiveness--the curious resilience of the $50,000-per-QALY threshold.
The ratio of $50,000 per quality-adjusted life-year (QALY) gained by using a given health care intervention has long served as a benchmark for the value of U.S. health care. But evidence suggests… Expand
Long-term Persistence in Use of Statin Therapy in Elderly Patients
ContextKnowledge of long-term persistence with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor (statin) therapy is limited because previous studies have observed patients for short periods… Expand
Economic impact of childhood and adult attention-deficit/hyperactivity disorder in the United States.
- J. Doshi, P. Hodgkins, +5 authors P. Neumann
- Medicine, Psychology
- Journal of the American Academy of Child and…
- 1 October 2012
OBJECTIVE Attention-deficit/hyperactivity disorder (ADHD) is one of the most prevalent mental disorders in children in the United States and often persists into adulthood with associated… Expand
Using real-world data for coverage and payment decisions: the ISPOR Real-World Data Task Force report.
- L. Garrison, P. Neumann, P. Erickson, D. Marshall, C. Mullins
- Value in health : the journal of the…
- 1 September 2007
OBJECTIVES Health decision-makers involved with coverage and payment policies are increasingly developing policies that seek information on "real-world" (RW) outcomes. Motivated by these initiatives,… Expand
Examining the value and quality of health economic analyses: implications of utilizing the QHES.
OBJECTIVE To examine the increasing use of health economic studies and practical implications of evaluating their quality utilizing the Quality of Health Economic Studies (QHES) instrument. METHODS… Expand
Long-term persistence in use of statin therapy in elderly patients.
CONTEXT Knowledge of long-term persistence with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor (statin) therapy is limited because previous studies have observed patients for short periods… Expand
Key principles for the improved conduct of health technology assessments for resource allocation decisions.
- M. Drummond, J. Schwartz, +4 authors S. Sullivan
- Medicine, Economics
- International journal of technology assessment in…
- 1 July 2008
Health technology assessment (HTA) is a dynamic, rapidly evolving process, embracing different types of assessments that inform real-world decisions about the value (i.e., benefits, risks, and costs)… Expand
Does preventive care save money? Health economics and the presidential candidates.
A popular component of the candidates' plans for controlling spiraling health care costs involves greater promotion of preventive health measures. Joshua Cohen, Peter Neumann, and Milton Weinstein… Expand
Development and Validation of a Grading System for the Quality of Cost-Effectiveness Studies
Purpose.To provide a practical quantitative tool for appraising the quality of cost-effectiveness (CE) studies. Methods.A committee comprised of health economists selected a set of criteria for the… Expand